Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shandong Pharmaceutical Glass Co., Ltd (600529.SS)
Zibo, CN
Shandong Pharmaceutical Glass Co., Ltd (SPG), headquartered in Zibo, China, is a manufacturer and supplier specializing in pharmaceutical glass packaging and related butyl rubber products. The company's extensive product portfolio encompasses a diverse range of glass packaging solutions. This includes essential items like molded injection vials, tubular glass vials, and ampoules, alongside various borosilicate glass products. SPG also supplies specialized containers such as amber, cobalt blue, and green bottles, as well as clear cosmetic and food-grade bottles. Beyond glass, SPG produces critical components like butyl rubber stoppers (including Teflon-coated variants), various plastic and aluminum caps, and dropper caps. They also provide prefilled syringes and plastic bottles. These offerings primarily cater to the pharmaceutical, food, and cosmetic packaging sectors. While maintaining a significant presence in the domestic Chinese market, SPG also extends its reach globally, exporting to numerous international markets such as Europe, the United States, Russia, Japan, Korea, and Southeast Asia. Established in 1970, the company boasts a long history in the industry.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.91% | +4.18% | +2.90% | -5.56% | -4.72% | -3.76% | -10.67% | -26.54% | -50.41% | +119.95% | +535.10% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaging & Containers: +2.6%-12.7% Q1'26: -1.9% (vs Q1'25)
-
EPS growth Packaging & Containers: +8.0%-26.8% Q1'26: -11.8% (vs Q1'25)
-
FCF margin FCF growth · Packaging & Containers: +34.6%+5.0% Q1'26: +0.6% (vs Q1'25)
-
EBIT margin Packaging & Containers: +7.0%+18.6% ★ Q1'26: +19.3% (vs Q1'25)
-
ROIC Packaging & Containers: +6.2%+12.4% ★ Q1'26: +12.8% (vs Q1'25)
-
Share dilution Packaging & Containers: +0.2%-0.2% Q1'26: +0.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaging & Containers: 0.83×0.02× ★ Q1'26: 0.59× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.06B
est: 1.90B (+8.2%)
|
2.33B
est: 2.33B (-0.1%)
|
2.58B
est: 2.62B (-1.2%)
|
2.99B
est: 2.89B (+3.6%)
|
3.43B
est: 3.35B (+2.4%)
|
3.88B
est: 3.93B (-1.3%)
|
4.19B
est: 4.18B (+0.3%)
|
4.98B
est: 5.15B (-3.2%)
|
5.13B
est: 5.13B (+0.0%)
|
4.47B
est: 4.61B (-3.0%)
|
4.93B
4.47B – 5.29B
+6.9% YoY
|
5.20B
4.99B – 5.41B
+5.4% YoY
|
5.47B
5.41B – 5.54B
+5.3% YoY
|
| EBITDA |
405.46M
est: 469.33M (-13.6%)
|
453.58M
est: 575.74M (-21.2%)
|
553.74M
est: 645.88M (-14.3%)
|
695.85M
est: 712.76M (-2.4%)
|
879.26M
est: 826.23M (+6.4%)
|
919.03M
est: 969.85M (-5.2%)
|
958.13M
est: 1.03B (-7.0%)
|
1.17B
est: 1.70B (-31.1%)
|
1.42B
est: 1.70B (-16.5%)
|
1.23B
est: 1.53B (-19.7%)
|
1.63B
1.48B – 1.75B
+6.9% YoY
|
1.72B
1.65B – 1.79B
+5.4% YoY
|
1.81B
1.79B – 1.83B
+5.3% YoY
|
| EBIT |
269.40M
est: 341.39M (-21.1%)
|
307.89M
est: 418.79M (-26.5%)
|
406.96M
est: 469.81M (-13.4%)
|
526.75M
est: 518.46M (+1.6%)
|
661.36M
est: 601.00M (+10.0%)
|
678.38M
est: 705.47M (-3.8%)
|
662.95M
est: 749.79M (-11.6%)
|
848.58M
est: 1.12B (-24.1%)
|
1.03B
est: 1.11B (-7.3%)
|
831.34M
est: 1.00B (-17.0%)
|
1.07B
971.82M – 1.15B
+6.9% YoY
|
1.13B
1.08B – 1.17B
+5.4% YoY
|
1.19B
1.17B – 1.20B
+5.3% YoY
|
| Net Income |
189.60M
est: 189.73M (-0.1%)
|
262.76M
est: 304.93M (-13.8%)
|
358.21M
est: 379.47M (-5.6%)
|
458.69M
est: 517.98M (-11.4%)
|
564.44M
est: 633.09M (-10.8%)
|
591.09M
est: 726.50M (-18.6%)
|
618.29M
est: 714.36M (-13.4%)
|
775.80M
est: 865.46M (-10.4%)
|
942.99M
est: 947.45M (-0.5%)
|
689.63M
est: 843.15M (-18.2%)
|
776.90M
725.04M – 851.49M
-7.9% YoY
|
817.15M
799.76M – 939.24M
+5.2% YoY
|
946.36M
870.45M – 1.02B
+15.8% YoY
|
| SGA |
307.43M
est: 120.94M (+154.2%)
|
302.56M
est: 148.36M (+103.9%)
|
338.75M
est: 166.43M (+103.5%)
|
362.67M
est: 183.66M (+97.5%)
|
227.96M
est: 212.90M (+7.1%)
|
230.19M
est: 249.91M (-7.9%)
|
251.59M
est: 265.61M (-5.3%)
|
332.17M
est: 283.05M (+17.4%)
|
335.28M
est: 281.92M (+18.9%)
|
104.98M
est: 253.77M (-58.6%)
|
271.29M
246.13M – 290.90M
+6.9% YoY
|
285.89M
274.39M – 297.40M
+5.4% YoY
|
301.10M
297.42M – 304.79M
+5.3% YoY
|
| EPS |
0.38
est: 0.29 (+33.0%)
|
0.44
est: 0.46 (-3.3%)
|
0.60
est: 0.57 (+5.0%)
|
0.77
est: 0.78 (-1.3%)
|
0.95
est: 0.95 (-0.3%)
|
0.99
est: 1.09 (-9.5%)
|
1.03
est: 1.08 (-4.2%)
|
1.17
est: 1.31 (-10.4%)
|
1.42
est: 1.44 (-1.3%)
|
1.04
est: 1.28 (-18.8%)
|
1.20
1.09 – 1.28
-6.5% YoY
|
1.32
1.21 – 1.42
+10.3% YoY
|
1.44
1.31 – 1.54
+8.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 2/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 2/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 2/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 2/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 2/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 2/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 2/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L | 0.04% | 6.0K | 0.65% |
| 2 | Franklin FTSE China ETF FLCH | 0.01% | 17.7K | 0.19% |
| 3 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 81.9K | 0.19% |
| 4 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 305.3K | 0.39% |
| 5 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 48.9K | 0.46% |
| 6 | Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX | 0.00% | 10.8K | 0.40% |
| 7 | Schwab Emerging Markets Equity ETF SCHE | 0.00% | 186.0K | 0.06% |
| 8 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 121.9K | 0.29% |
| 9 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 15.3K | 0.48% |
| 10 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 34.4K | 0.26% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bin Du | Deputy General Manager | — | male |
| Gang Chen | Executive Deputy GM & Director | — | male |
| Haibao Zhao | Secretary of the Board of Directors | — | male |
| Jun Zhang | GM & Director | — | male |
| Mianxing Liu | Accounting Supervisor | — | — |
| Wansheng He | Deputy General Manager | — | male |
| Xingjun Wang | Deputy GM & Director | — | male |
| Yizhao Song | Deputy GM & CFO | — | male |
| Yucai Su | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600529.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
